Ventricular Tachycardia
📧 Sign up to get email alerts when something new happens for Ventricular Tachycardia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-03Clinical Trial Update: AVAI: Atrial Ventricular Arrythmia Incidence
This clinical trial update reports completed results (posted 2015-03-03) from Abbott Medical Devices on the incidence of atrial-ventricular …
-
FDA approval · 2015-03-02FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (AiPing Pharmaceutical, Inc.)
FDA approved AiPing Pharmaceutical, Inc.'s supplemental application for sotalol hydrochloride, confirming approval of a generic product's su…
-
FDA approval · 2015-02-17FDA Approved: FLECAINIDE ACETATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for flecainide acetate from Hikma Pharmaceuticals USA Inc., expanding or authorizing changes to this…
-
CLINICAL_TRIALS research · 2015-02-09Clinical Trial Update: Ventricular Tachycardia in Ischemic Cardiomyopathy; a Combined Endo-Epicardial Ablation Within the First Procedure Versus a Stepwise Approach [NA]
This document describes a clinical trial evaluating performing a combined endocardial and epicardial ablation in the first procedure versus …
-
CLINICAL_TRIALS withdrawal · 2015-01-27Clinical Trial Update: Trial Comparing Ablation With Medical Therapy in Patients With Ventricular Tachycardia [Phase 3]
A Phase 3 trial comparing ablation versus medical therapy for ventricular tachycardia has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: Survival of Patients With Primary Prophylactic ICD Indication [Phase 4]
This Phase 4 trial update reports survival outcomes for patients with a primary prophylactic ICD indication. The study was sponsored by Biot…
-
CLINICAL_TRIALS trial_result · 2015-01-01Clinical Trial Update: Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators [Phase 4]
Phase 4 trial evaluating early ablation therapy for ischemic ventricular tachycardia in patients with implantable cardioverter-defibrillator…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Influence of Home Monitoring on the Clinical Status of Heart Failure Patients With an Impaired Left Ventricular Function [Phase 4]
Phase 4 trial evaluating home monitoring for patients with heart failure and impaired left ventricular function; the study has completed.
-
FDA approval · 2014-12-21FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for amiodarone hydrochloride submitted by Sun Pharmaceutical Industries, signifying a regulatory…
-
FDA approval · 2014-12-21FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approves a supplemental application for amiodarone hydrochloride from Sun Pharmaceutical Industries, Inc., indicating regulatory approva…
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: Remifentanil Intravenous Patient Controlled Analgesia (IVPCA) for Ablation of Idiopathic Ventricular Tachycardia [Phase 4]
Phase 4 trial update on remifentanil IVPCA for ablation of idiopathic ventricular tachycardia; study completed with results posted.
-
FDA approval · 2014-10-22FDA Approved: SOTYLIZE — Original Application (Azurity Pharmaceuticals, Inc.)
FDA approved SOTYLIZE (sotalol hydrochloride) through an Original NDA from Azurity Pharmaceuticals for antiarrhythmic use.
-
CLINICAL_TRIALS research · 2014-10-21Clinical Trial Update: Feasibility of Contact Force Catheter Mapping and Ablation in Epicardial and Endocardial Ventricular Tachycardias
Clinical trial update examining the feasibility of using contact force catheter mapping and ablation for epicardial and endocardial ventricu…
-
CLINICAL_TRIALS trial_result · 2014-10-16Clinical Trial Update: Catheter Evaluation for Endocardial Ablation in Patients With Ventricular Tachycardia [Phase 4]
This document reports the completion and posted results of a Phase 4 trial evaluating an endocardial ablation catheter for treating ventricu…
-
FDA label_change · 2014-09-29FDA Approved: NEXTERONE — Supplemental Application (Baxter Healthcare Company)
The FDA approved a supplemental application for NEXTERONE (amiodarone hydrochloride) from Baxter Healthcare Company, resulting in changes to…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Pilot Study of Catheter Ablation for Ventricular Tachycardia in Patients With an Implantable Cardioverter Defibrillator [NA]
A pilot study evaluating catheter ablation for ventricular tachycardia in patients with an implantable cardioverter-defibrillator was termin…
-
CLINICAL_TRIALS trial_result · 2014-08-25Clinical Trial Update: Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT Ablation [Phase 3]
A Phase 3 trial compared ablation of clinical ventricular tachycardia alone versus adding substrate ablation, assessing long-term success of…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: A Randomized Trial of Remote Monitoring of Implantable Cardioverter Defibrillators Versus Quarterly Device Interrogations in Clinic [NA]
This clinical trial compared remote monitoring of implantable cardioverter defibrillators to quarterly device interrogations and has complet…
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: Automatic External Defibrillation Monitoring in Cardiac Arrest [Phase 1]
Phase 1 clinical trial update evaluating automatic external defibrillation monitoring in cardiac arrest; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-06-11Clinical Trial Update: The Use of Dual Chamber ICD With Special Programmed Features to Lower the Risk of Inappropriate Shock [Phase 4]
Phase 4 clinical trial evaluating a dual-chamber implantable cardioverter-defibrillator with specialized programming features aimed at reduc…
-
CLINICAL_TRIALS trial_result · 2014-04-24Clinical Trial Update: Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia [NA]
The study update for a stepwise substrate modification approach in ventricular tachycardia using catheter ablation was terminated; results w…
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: Comparison of Right Ventricular Septal and Right Ventricular Apical Pacing in Patients Receiving a CRT-D Device [NA]
A clinical trial comparing right ventricular septal pacing and right ventricular apical pacing in patients with a CRT-D device has completed…
-
CLINICAL_TRIALS research · 2014-01-30Clinical Trial Update: Endo- and Epicardial vs. Endocardial Ablation of Ventricular Tachycardia in Patients With Cardiac Disease [NA]
This clinical trial compares endocardial ablation with endocardial plus epicardial ablation for ventricular tachycardia in patients with car…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Fast VT Episodes Are Terminated by ATP One Shot [Phase 4]
Phase 4 study shows that ATP therapy delivered in a single 'one-shot' can terminate fast episodes of monomorphic ventricular tachycardia.
-
CLINICAL_TRIALS trial_result · 2013-11-04Clinical Trial Update: Fibrillatory Factor in Ventricular Tachycardia [NA]
A clinical trial update related to fibrillatory factor in ventricular tachycardia; the current status of the trial is unknown.